Member Exclusive News

Experimental treatment against Staphylococcus Aureus

A new class of engineered proteins may counter infections caused by Staphylococcus aureus has been developed. This comes after a five-year research partnership between NYU School of Medicine (USA) and Janssen Research & Development (NJ, USA).

Go to the profile of Zoe Campbell
Jan 22, 2019

Please sign in or register for FREE

No comments yet.